Literature DB >> 8408935

Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients.

D Pittet1, B Thiévent, R P Wenzel, N Li, G Gurman, P M Suter.   

Abstract

OBJECTIVE: To determine admission characteristics associated with the outcome of septicemia in critically ill patients and more specifically assess the prognostic value of pre-existing co-morbidities.
DESIGN: 5 year-retrospective cohort study.
SETTING: Surgical Intensive Care Unit (ICU-20 beds) in a 1600 bed-tertiary care center. PATIENTS: Among 5457 patients admitted to the ICU between 1984 and 1988, 176 (3.2%) met prospectively-defined criteria for blood culture-proven septicemia (8.77 per 1000 patient-days). Overall septicemic patients had a 5-fold increased risk of death compared to non-septicemic patients (relative risk 5.03, 95% confidence intervals 4.17-6.07, p < 0.0001), and this estimate persisted after stratification according to age, sex, primary diagnosis and conditions of admission to the ICU (emergency/elective).
RESULTS: Prognostic factors recorded on admission to ICU that were associated with mortality from septicemia among 173 patients were older age, higher admission Apache II score, gastrointestinal surgery, ultimately and rapidly fatal diseases and the number of co-morbidities in addition to the principal diagnosis (active smoking, alcohol abuse, non-cured malignancy, diabetes mellitus, splenectomy, recent antibiotic therapy, major surgery, or major cardiac event). In the multivariate analysis with logistic regression procedures, Apache II and co-morbidities were identified as the two independent predictors of mortality.
CONCLUSIONS: Pre-existing co-morbidities assessed at the admission to the ICU significantly improved the prediction of mortality from septicemia compared to Apache II score alone.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408935     DOI: 10.1007/bf01690546

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  35 in total

1.  The importance of underlying disease in patients with gram-negative bacteremia.

Authors:  M A Freid; K L Vosti
Journal:  Arch Intern Med       Date:  1968-05

2.  A three-year study of positive blood cultures, with emphasis on prognosis.

Authors:  F J Roberts; I W Geere; A Coldman
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

3.  The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis.

Authors:  M P Weinstein; J R Murphy; L B Reller; K A Lichtenstein
Journal:  Rev Infect Dis       Date:  1983 Jan-Feb

4.  APACHE-acute physiology and chronic health evaluation: a physiologically based classification system.

Authors:  W A Knaus; J E Zimmerman; D P Wagner; E A Draper; D E Lawrence
Journal:  Crit Care Med       Date:  1981-08       Impact factor: 7.598

5.  Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial.

Authors:  T Calandra; M P Glauser; J Schellekens; J Verhoef
Journal:  J Infect Dis       Date:  1988-08       Impact factor: 5.226

6.  Comparison of clinical assessment with APACHE II for predicting mortality risk in patients admitted to a medical intensive care unit.

Authors:  J A Kruse; M C Thill-Baharozian; R W Carlson
Journal:  JAMA       Date:  1988 Sep 23-30       Impact factor: 56.272

7.  Measuring the costs of nosocomial infections: methods for estimating economic burden on the hospital.

Authors:  R W Haley
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

Review 8.  Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy.

Authors:  C S Bryan; K L Reynolds; E R Brenner
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

9.  Nosocomial infection among patients in different types of intensive care units at a city hospital.

Authors:  P H Chandrasekar; J A Kruse; M F Mathews
Journal:  Crit Care Med       Date:  1986-05       Impact factor: 7.598

10.  Financial risk, hospital cost, complications, and comorbidities in surgical noncomplication- and noncomorbidity-stratified diagnostic related groups.

Authors:  E Munoz; H Sterman; J Cohen; J Goldstein; I B Margolis; L Wise
Journal:  Ann Surg       Date:  1988-03       Impact factor: 12.969

View more
  50 in total

1.  Risk factors for 90-day and 180-day mortality in hospitalised patients with pressure ulcers.

Authors:  Anna Flattau; Arthur E Blank
Journal:  Int Wound J       Date:  2012-06-28       Impact factor: 3.315

2.  Crude reality versus data manipulation: is the glass always crystal clear?

Authors:  Heleen M Oudemans-van Straaten; Jean-Jacques Parienti
Journal:  Intensive Care Med       Date:  2016-01-20       Impact factor: 17.440

Review 3.  The use of severity scores in the intensive care unit.

Authors:  Jean-Roger Le Gall
Journal:  Intensive Care Med       Date:  2005-10-22       Impact factor: 17.440

4.  De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock.

Authors:  J Garnacho-Montero; A Gutiérrez-Pizarraya; A Escoresca-Ortega; Y Corcia-Palomo; Esperanza Fernández-Delgado; I Herrera-Melero; C Ortiz-Leyba; J A Márquez-Vácaro
Journal:  Intensive Care Med       Date:  2013-09-12       Impact factor: 17.440

5.  Systemic inflammatory response syndrome (SIRS) and sepsis in surgical patients.

Authors:  M D Menger; B Vollmar
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

6.  Dose-related effect of smoking on mortality in critically ill patients: a multicentre cohort study.

Authors:  Kwok M Ho; Graeme Hart; David Austin; Mike Hunter; John Botha; Shaila Chavan
Journal:  Intensive Care Med       Date:  2011-03-11       Impact factor: 17.440

7.  A double-blind placebo-controlled study of an infusion of lexipafant (Platelet-activating factor receptor antagonist) in patients with severe sepsis.

Authors:  Y Suputtamongkol; S Intaranongpai; M D Smith; B Angus; W Chaowagul; C Permpikul; J A Simpson; A Leelarasamee; L Curtis; N J White
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

8.  Patients with diabetes in the intensive care unit; not served by treatment, yet protected?

Authors:  Sarah E Siegelaar; J Hans Devries; Joost B Hoekstra
Journal:  Crit Care       Date:  2010-03-01       Impact factor: 9.097

9.  Insulin-treated diabetes is not associated with increased mortality in critically ill patients.

Authors:  Jean-Louis Vincent; Jean-Charles Preiser; Charles L Sprung; Rui Moreno; Yasser Sakr
Journal:  Crit Care       Date:  2010-02-04       Impact factor: 9.097

Review 10.  The stressed host response to infection: the disruptive signals and rhythms of systemic inflammation.

Authors:  Stephen F Lowry
Journal:  Surg Clin North Am       Date:  2009-04       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.